None listed
Conditions
Interventions
Intervention1: Non-surgical periodontal therapy ALP and ACP reagent: At Day 1 a written consent form was obtained from each patient. Initial clinical examination, including bleeding on probing (BOP),
Sponsors
DrSupriti dutta
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subjects unable to provide informed consent or comply with study protocol. 2. Patients with oral potentially malignant disorders and systemic illnesses such as diabetes, hypertension, thyroid or any known endocrine disorders, osteoarthritis, osteosarcoma, and renal failure were excluded. 3. Subjects with presence of fixed prosthesis and orthodontics appliances. 4. Patients presented with systemic disease, pregnant female, lactating or postmenopausal female.
Exclusion criteria
Exclusion criteria: 1. Subjects unable to provide informed consent or comply with study protocol. 2. Patients with oral potentially malignant disorders and systemic illnesses such as diabetes, hypertension, thyroid or any known endocrine disorders, osteoarthritis, osteosarcoma, and renal failure were excluded. 3. Subjects with presence of fixed prosthesis and orthodontics appliances. 4. Patients presented with systemic disease, pregnant female, lactating or postmenopausal female.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcomes were changes in alkaline phosphatase (ALP) and acid phosphatase (ACP) levels in saliva following periodontal therapy along with gingival index,plaque index,clinical attachment level and probing depth and comparing before and after result.Timepoint: The primary outcomes were changes in alkaline phosphatase (ALP) and acid phosphatase (ACP) levels in saliva following periodontal therapy at baseline,15th day and 4week along with gingival index,plaque index,clinical attachment level and probing depth at baseline and 4weeks and comparing before and after result. | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical periodontal parameters including probing pocket depth (PPD), clinical attachment level (CAL), plaque index (PI), & gingival index (GI) were assessed at baseline & at 4week post-treatment to evaluate the clinical effectiveness of periodontal therapy in current smoker,former smoker & non-smoker groups.Timepoint: Clinical parameters including probing pocket depth (PPD), clinical attachment level (CAL), gingival index (GI), plaque index (PI) were recorded at baseline (Day 0) & at 4 weeks post-treatment, corresponding with the biochemical follow-up at baseline,15th day & 4week. | — |
Countries
India
Contacts
Public ContactDr Supriti Dutta
Nims Dental College and hospital,Jaipur
Outcome results
None listed